Please login to the form below
Positive results for GSK/CureVac’s COVID-19 vaccine
Vaccine candidate generated strong immune responses in preclinical testing
Biogen and Envisagenics to advance RNA splicing research for CNS diseases
Envisagenics’ SpliceCore platform can be used to identify, test and validate RNA splicing errors at scale
New trial data for Keytruda in triple-negative breast cancer
Keytruda plus chemotherapy showed significant and meaningful improvement
NICE recommends Keytruda for colorectal cancer patients with rare mutations
Approximately 450 patients in England will now become eligible for this treatment on the NHS
Developers of COVID-19 vaccines and therapeutics highlight continued need for treatments
Continued need for vaccines/treatments 'likely' as world moves into the next phase of the pandemic
Italy accelerates the path towards digital therapeutics implementation
PME talks to Roberto Ascione, Gualberto Gussoni and Giuseppe Recchia about the advancement of digital therapeutics in Italy
PMHub Videos and Podcasts
<>- How to Simplify Genetics & Raise Awareness Around Orphan Diseases
- Exploring Digital Health From a Patient Perspective
- Nanobiotechnology, Artificial Intelligence, and Virtual Care
- Virtual Trials, Remote Care, & Cross-Border Collaboration: Ethical & Legal Challenges
- How Patient Advocacy Can Positively Disrupt Healthcare
- Leaders in Pharma: Danielle Portnik
The Gallery
<>A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.
Agency:
Life Healthcare CommunicationsProduct:
Self PromotionClient:
Self PromotionTherapy area:
Self Promotion
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story
VMLY&Rx launches new payer agency in the US
VMLY&Rx Payer will be helmed by healthcare comms industry veteran HeeSun Yu
Clark Health promotes Siân Hurst to managing director role
Hurst initially joined the agency with over 20 years of experience in healthcare communications
Novartis and smartpatient launch app experience for wet AMD patients
Wet AMD is the leading cause of severe vision loss and legal blindness in people over the age of 65
The impact of cancer on mental health during COVID-19
by Hubert Bland, Executive Medical Director, Bristol Myers Squibb UK and Ireland
Pharma marketers' blog: How to be a patient-centric pharma marketer?
Understanding that patients are a person first and a patient second
Creating communication magic, without tricks
Successful healthcare communications need to bring their audience on the journey as a willing and cognisant partner
COVID-19 Updates and Daily News
Featured jobs
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
-
Medical Editor
-
Competitive Salary
-
Senior Account Executive
-
Competitive Salary
-
Senior Medical Writer
-
Competitive Salary
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Group Account Director, Healthcare Advertising/ Brand comms, Lon...
-
8 month contract up to £90K
-
Account Manager
-
Competitive Salary
- Head of Strategic Planning, Healthcare Advertising/ Brand comms,...
-
Six figure salary
- Account Manager / Senior Account Manager - Creative MedComms - C...
-
Excellent Remuneration
- Senior Medical Writer– Medical Education – Oxford - London
-
Excellent Remuneration Package
- Account Manager - Creative Healthcare Communications - South Wes...
-
Excellent Remuneration
-
Publications Director
-
Competitive Salary
- Senior & Principal Medical Writer
-
Competitive Salary Offered
-
Associate Account Director
-
Competitive Salary
-
Account Management
-
Competitive Salary Offered
- Senior Account Manager/ Account Director
-
Competitive Salary Offered
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Merck & Co reveals plans for women’s health spinoff Organon
- EMA launches rolling review of GSK/Vir Biotech’s mAb for early COVID-19
- Novavax is close to finalising a COVID-19 vaccine supply deal with the EU
- VMLY&Rx launches new payer agency in the US
- AbbVie lauds head-to-head win for Skyrizi versus Cosentyx
- Research Partnership’s MedTech Division appoints two Directors
- VMLY&Rx launches new payer agency in the US
- Biogen and Envisagenics to advance RNA splicing research for CNS diseases
- Positive results for GSK/CureVac’s COVID-19 vaccine
- New trial data for Keytruda in triple-negative breast cancer
- NICE recommends Keytruda for colorectal cancer patients with rare mutations
- Merck & Co reveals plans for women’s health spinoff Organon
- Why female mentorship is so powerful in pharma
- Oxford University to investigate nasal spray delivery of AZ-partnered COVID-19 vaccine
- Can protein degraders unlock ‘undruggable’ drug targets?
- Has AI been the key to tackling the COVID-19 pandemic?
- Merck & Co halts development of potential COVID-19 drug MK-7110
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...Latest intelligence
- How innovating study sites can improve patient recruitment efficiency
- There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
- Avoiding A Series of Unfortunate Events: launch lessons from lockdown
- Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
- 6 reasons patients drop out of clinical trials and 6 ways to fix it
- If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....
